Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy.
about
Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injuryNovel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions-A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of CardiologyPGC-1 proteins and heart failureOptimization of cardiac metabolism in heart failureThe cell biology of disease: cellular mechanisms of cardiomyopathy.Mitochondrial pyruvate transport: a historical perspective and future research directionsMitochondria in heart failureCardiac-specific hexokinase 2 overexpression attenuates hypertrophy by increasing pentose phosphate pathway fluxMetabolic profiles in heart failure due to non-ischemic cardiomyopathy at rest and under exerciseEvidence of Glycolysis Up-Regulation and Pyruvate Mitochondrial Oxidation Mismatch During Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Reloading and ConditioningMeasuring regional changes in the diastolic deformation of the left ventricle of SHR rats using microPET technology and hyperelastic warping.Molecular determinants of the cardiometabolic phenotype.Radionuclide imaging of myocardial metabolismImaging and modeling of myocardial metabolismThe gut hormone ghrelin partially reverses energy substrate metabolic alterations in the failing heart.Changes in cardiac substrate transporters and metabolic proteins mirror the metabolic shift in patients with aortic stenosis.Translation of myocardial metabolic imaging concepts into the clinics.Acetyl-L-carnitine supplementation reverses the age-related decline in carnitine palmitoyltransferase 1 (CPT1) activity in interfibrillar mitochondria without changing the L-carnitine content in the rat heartAn analysis of the myocardial transcriptome in a mouse model of cardiac dysfunction with decreased cholinergic neurotransmission.Assessment of metabolic phenotypes in patients with non-ischemic dilated cardiomyopathy undergoing cardiac resynchronization therapy.The PGC-1 cascade as a therapeutic target for heart failureSynthesis and evaluation of 15-(4-(2-[¹⁸F]Fluoroethoxy)phenyl)pentadecanoic acid: a potential PET tracer for studying myocardial fatty acid metabolism.Longitudinal Evaluation of Fatty Acid Metabolism in Normal and Spontaneously Hypertensive Rat Hearts with Dynamic MicroSPECT Imaging.Modulating fatty acid oxidation in heart failure.Persistent overexpression of phosphoglycerate mutase, a glycolytic enzyme, modifies energy metabolism and reduces stress resistance of heart in micePPAR-alpha effects on the heart and other vascular tissues.Restoring redox balance enhances contractility in heart trabeculae from type 2 diabetic rats exposed to high glucose.Cardiovascular remodelling in coronary artery disease and heart failure.Hyperpolarized magnetic resonance: a novel technique for the in vivo assessment of cardiovascular disease.Pre-clinical myocardial metabolic alterations in chronic kidney disease.Chronic heart failure selectively induces regional heterogeneity of insulin-responsive glucose transporters.Diabetes and the risk of heart failureAltered systemic ketone body metabolism in advanced heart failure.Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic diet.Diabetes Alters the Expression and Translocation of the Insulin-Sensitive Glucose Transporters 4 and 8 in the Atria.Transcriptional control of cardiac fuel metabolism and mitochondrial functionSevere pulmonary hypertension is associated with altered right ventricle metabolic substrate uptakeMitochondrial energy metabolism in heart failure: a question of balance.Loss of long-chain acyl-CoA synthetase isoform 1 impairs cardiac autophagy and mitochondrial structure through mechanistic target of rapamycin complex 1 activation.Metabolic energetics and genetics in the heart.
P2860
Q24632770-8B938C0B-5A11-40F0-9D6A-B143577C34F3Q26765793-787286F0-4EA7-4A3A-9112-A9FE9A835F66Q27008861-1DB19009-BC51-413B-835A-11FFC194B5D0Q27023021-476D86E6-B11C-4A4F-B70F-9632552D8F45Q27686758-0556250D-9A89-46BA-8188-B85AD1A243E1Q28085025-5A59BAA9-52FF-4895-8DFC-3C350B8BE9E4Q28385915-41573905-083E-4719-8F4D-4F49EACE8A4EQ28572802-7AA3A053-8F88-44D5-9A3A-B9260906183AQ33577400-6B60A9C4-0A16-428A-BD78-8564590382D0Q33651722-7F923B7A-479F-4F14-B1E3-C7E21AAD74DBQ33854288-7C0D6D57-B81C-41A8-AF7B-4B5B29560739Q33921392-E87C2CCA-CC14-4CCE-B22F-6D3C14B63D1BQ33943594-1693BD43-C215-4FDE-BACD-3803546F1ABEQ33970067-BF3E6366-F10B-4483-BDEB-872D833E09CCQ33986863-6B7F5DE8-1929-40CE-849E-112AC66184DAQ34058517-93407D8A-3AE7-4E83-A904-C0E2BA8A6567Q34089975-38ACA748-4368-4E7C-9354-D3034AE37F36Q34102948-E5698B9D-C663-449E-A269-8EF03067A4F7Q34328505-96C272A5-82DE-4336-9628-CF83A1758963Q34361776-E71CFB22-C039-4567-AFF5-3C039372FA0AQ34587748-FFCF2510-E9D2-493B-90BD-8E3CC96ED049Q34700405-3EEE9F4A-7CF7-48F5-9C8E-AC7BA3A9BFFAQ34769220-00BE02AC-2949-4E0A-AC67-D4DD7F9A6528Q34808505-C7803872-107F-4D99-8108-C2CB87FD2639Q34951279-F71415FD-4A55-4901-BA70-A7F158CBF343Q35080447-2FFAF8B6-6A7B-4058-84BF-25361836DEECQ35086430-B13B9267-EF84-4B56-8BFE-4E7841A7462BQ35090566-0A919940-7361-4617-A801-C54E4AB8D8A7Q35298233-641EFBD9-B560-4E32-8221-18E15638382CQ35460057-CB771A85-25AC-4188-836C-FE073F3AC5EBQ35543414-CC1B383F-1713-400D-B1B8-E27CB35BBD9BQ35571144-728972EA-EEE7-43B5-99FA-40CF950EE2FAQ35594825-7C695204-0194-4292-A48C-A97B9F997D2EQ35621184-6676EA4B-9AA4-46B7-9FB5-462325DCF408Q35882714-85279C9D-8127-4697-AD2B-817E28BB3853Q35923008-3A8BF9EE-0738-4890-A3B6-7DF3FFACF25EQ36017769-F4B9A499-6781-4B0A-A5FA-BC336AD163D8Q36070074-CD9C4F34-A151-4E6A-BCD1-AB51D803DC0CQ36171264-EFFD3798-89AB-4B5F-82CE-C188038F9FA1Q36225161-2E301CA1-B608-4963-95D0-41631C3454A5
P2860
Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Altered myocardial fatty acid ...... pathic dilated cardiomyopathy.
@en
Altered myocardial fatty acid ...... pathic dilated cardiomyopathy.
@nl
type
label
Altered myocardial fatty acid ...... pathic dilated cardiomyopathy.
@en
Altered myocardial fatty acid ...... pathic dilated cardiomyopathy.
@nl
prefLabel
Altered myocardial fatty acid ...... pathic dilated cardiomyopathy.
@en
Altered myocardial fatty acid ...... pathic dilated cardiomyopathy.
@nl
P2093
P1476
Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy
@en
P2093
Daniel P Kelly
Giridhar Vedala
Joseph G Rogers
Pilar Herrero
Robert J Gropler
Víctor G Dávila-Román
P304
P356
10.1016/S0735-1097(02)01967-8
P407
P577
2002-07-01T00:00:00Z